Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels

NCT04312347 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
151
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nalagenetics Pte Ltd